Our Approach
The BioPür Process® is our
Platform Technology
We create products from qualified ‘single birth’ placental donors.
We create products across 3 categories:
Membrane patches
Injectable regenerative therapeutics
Topical cosmetics
Technology innovation
BioXtek’s manufacturing platform, expansive IP development programs, and regulatory pathways create:
01
Competitive advantage
Our omni-channel approach provides competitive advantage in different markets; each with significant growth potential.
02
Revenue trajectory
Already revenue-generating, BioXtek’s commercial plans target both near-term and larger,longer-term market opportunities.
03
Dry eye
Wound care
Orthopedics
Membrane patches
FDA 361 to 510k
Regenerative organ therapeutics
Pulmonary arterial hypertension
Injectable regenerative therapeutics
Clinical trials
Regenerative aesthetics products
Topical cosmetics
cGMP and cGTP
Scalable and stable production
Ongoing R&D and active trials
IP portfolio
Utilizing cryopreservation and freeze-drying technologies to concentrate and focus the biological active components:
- Exosomes and their cargo
- Growth factors
- Peptides
- Cytokines
- miRNA
- Mesenchymal stem cells
